Clinical Scorecard: Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma: A New Approach?
At a Glance
Category
Detail
Condition
Key Mechanisms
MMA embolization may target the underlying pathophysiology of cSDH by occluding the middle meningeal artery to prevent recurrent bleeding, pending source attribution.
Target Population
Care Setting
Key Highlights
MMA embolization has shown lower recurrence rates compared to conventional management, pending source attribution.
Guideline-Based Recommendations
Diagnosis
Management
MMA embolization may be considered for recurrent cases or poor surgical candidates, pending source attribution.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with symptomatic chronic subdural hematoma, particularly older adults.
MMA embolization may serve as a primary therapy option or adjunct to surgical management.
Clinical Best Practices
Consideration of MMA embolization for patients with recurrent cSDH or those at high risk for recurrence should be directly sourced.
by Yan Li, Johannes Haubold, Natalie van Landeghem, Cornelius Deuschl, Ramazan Jabbarli, Philipp Dammann, Ulrich Sure, Isabel Wanke, Luisa Strack, Michael Forsting
